表紙
市場調査レポート

通年性アレルギー性鼻炎:世界の治験レビュー

Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 322163
出版日 ページ情報 英文 117 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
通年性アレルギー性鼻炎:世界の治験レビュー Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 117 Pages
概要

当レポートでは、通年性アレルギー性鼻炎の臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 通年性アレルギー性鼻炎
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要国における治験件数
    • 中南米の主要国における治験件数

G7諸国での治験件数:呼吸器系疾患の治験における通年性アレルギー性鼻炎の割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:呼吸器系疾患の治験における通年性アレルギー性鼻炎の割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

スポンサーの種類別の治験件数

有望なスポンサー

通年性アレルギー性鼻炎治療薬の治験に携わっている主要企業

有望な薬剤

最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • GlaxoSmithKline plc
    • Merck & Co., Inc.
    • UCB S.A.
    • 武田薬品工業
    • 大日本住友製薬
    • Sanofi
    • Teva Pharmaceutical Industries Limited
    • Novartis AG
    • Meda AB
    • C. H. Boehringer Sohn AG & Co. KG
  • 代表的な研究機関・病院の治験の概要
    • University of Chicago
    • The National Institute of Allergy and Infectious Diseases
    • 福井大学
    • 千葉大学
    • Mahidol University
    • China Medical University Hospital
    • University of Nottingham
    • University of South Florida
    • University of Sao Paulo
    • Chinese University of Hong Kong

5つの代表的な治験のプロファイル

付録

目次
Product Code: GDHC2504CTIDB

GlobalData's clinical trial report, "Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2014" provides data on the Perennial Allergic Rhinitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Perennial Allergic Rhinitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Perennial Allergic Rhinitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Perennial Allergic Rhinitis
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Perennial Allergic Rhinitis to Respiratory Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Perennial Allergic Rhinitis to Respiratory Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Perennial Allergic Rhinitis
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Perennial Allergic Rhinitis Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Perennial Allergic Rhinitis
    • Nov 07, 2014: Teva Presents Positive Safety and Efficacy Data for QNASL (Beclomethasone Dipropionate) Nasal Aerosol in Treating Children with Perennial Allergic Rhinitis
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • UCB S.A.
      • Clinical Trial Overview of UCB S.A.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Sumitomo Dainippon Pharma Co., Ltd.
      • Clinical Trial Overview of Sumitomo Dainippon Pharma Co., Ltd.
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Teva Pharmaceutical Industries Limited
      • Clinical Trial Overview of Teva Pharmaceutical Industries Limited
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Meda AB
      • Clinical Trial Overview of Meda AB
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
    • Clinical Trial Overview of Top Institutes / Government
      • University of Chicago
      • Clinical Trial Overview of University of Chicago
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • University of Fukui
      • Clinical Trial Overview of University of Fukui
      • Chiba University
      • Clinical Trial Overview of Chiba University
      • Mahidol University
      • Clinical Trial Overview of Mahidol University
      • China Medical University Hospital
      • Clinical Trial Overview of China Medical University Hospital
      • University of Nottingham
      • Clinical Trial Overview of University of Nottingham
      • University of South Florida
      • Clinical Trial Overview of University of South Florida
      • University of Sao Paulo
      • Clinical Trial Overview of University of Sao Paulo
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region, 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Countries, 2014*
  • Proportion of Perennial Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Perennial Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Perennial Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Perennial Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Perennial Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by UCB S.A., 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sumitomo Dainippon Pharma Co., Ltd., 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Meda AB, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Fukui, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chiba University, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mahidol University, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nottingham, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of South Florida, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014*

List of Figures

  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014*
  • Proportion of Perennial Allergic Rhinitis to Respiratory Clinical Trials, G7 Countries (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Perennial Allergic Rhinitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Perennial Allergic Rhinitis to Respiratory Clinical Trials, E7 Countries (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Perennial Allergic Rhinitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Perennial Allergic Rhinitis Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Perennial Allergic Rhinitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Perennial Allergic Rhinitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top